Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 5
2020 14
2021 80
2022 42
2023 23
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Results by year

Filters applied: . Clear all
Page 1
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis.
Wenzel M, Nocera L, Collà Ruvolo C, Würnschimmel C, Tian Z, Shariat SF, Saad F, Tilki D, Graefen M, Kluth LA, Briganti A, Mandel P, Montorsi F, Chun FKH, Karakiewicz PI. Wenzel M, et al. Prostate Cancer Prostatic Dis. 2022 Feb;25(2):139-148. doi: 10.1038/s41391-021-00395-4. Epub 2021 May 30. Prostate Cancer Prostatic Dis. 2022. PMID: 34054128 Free PMC article. Review.
Reply by Authors.
Wenzel M, Nocera L, Collà Ruvolo C, Würnschimmel C, Tian Z, Shariat SF, Saad F, Briganti A, Tilki D, Graefen M, Kluth LA, Mandel P, Chun FKH, Karakiewicz PI. Wenzel M, et al. J Urol. 2021 Jul;206(1):79. doi: 10.1097/JU.0000000000001695.03. Epub 2021 Apr 6. J Urol. 2021. PMID: 33820427 No abstract available.
Dusting, fragmenting, popcorning or dustmenting?
Wenzel M, Bultitude M, Salem J. Wenzel M, et al. Curr Opin Urol. 2019 Mar;29(2):108-112. doi: 10.1097/MOU.0000000000000580. Curr Opin Urol. 2019. PMID: 30550408 Review.
[Metastatic castration-resistant prostate cancer].
Henriques V, Wenzel M, Demes MC, Köllermann J. Henriques V, et al. Among authors: wenzel m. Pathologe. 2021 Jul;42(4):431-441. doi: 10.1007/s00292-021-00956-3. Epub 2021 Jun 25. Pathologe. 2021. PMID: 34170384 Review. German.
Immuno-oncology therapy in metastatic bladder cancer: A systematic review and network meta-analysis.
Chierigo F, Wenzel M, Würnschimmel C, Flammia RS, Horlemann B, Tian Z, Saad F, Chun FKH, Tilki D, Shariat SF, Gallucci M, Borghesi M, Suardi N, Terrone C, Karakiewicz PI. Chierigo F, et al. Among authors: wenzel m. Crit Rev Oncol Hematol. 2022 Jan;169:103534. doi: 10.1016/j.critrevonc.2021.103534. Epub 2021 Nov 22. Crit Rev Oncol Hematol. 2022. PMID: 34823022 Review.
137 results